Endokrynologia Polska

Via Medica

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Endokrynologia Polska is an open-access journal published by Via Medica in Poland, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 700 EUR. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Via Medica
ISSN
0423-104X · 2299-8306
Country
Poland
Languages
english
Access
Open access
Declared publication charge
700 EUR
Articles in DOAJ
283
Declared review time
20 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-03-04
  • MEDLINE · 1965-01-01
Indexing
DOAJ · MEDLINE
APC
700 EUR
Declared review time (DOAJ)
20 weeks
Actual review time (measured)
56 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

283

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

1167

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

39

i10-index

318

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2025-03-21
Added to DOAJ
2016-03-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Polish Journal of EndocrinologyEP
Source type
journal
NLM unique ID (PubMed)
0370674
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Thyroid Disorders and Treatments
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • Thyroid Cancer Diagnosis and Treatment
  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Thyroid Disorders and Treatments
Show all subjects (75)
  • Thyroid Disorders and Treatments
  • Pituitary Gland Disorders and Treatments
  • Pituitary Gland Disorders and Treatments
  • Adrenal Hormones and Disorders
  • Adrenal and Paraganglionic Tumors
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Adipokines, Inflammation, and Metabolic Diseases
  • Thyroid and Parathyroid Surgery
  • Thyroid and Parathyroid Surgery
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Adrenal and Paraganglionic Tumors
  • Parathyroid Disorders and Treatments
  • Adrenal and Paraganglionic Tumors
  • Parathyroid Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Parathyroid Disorders and Treatments
  • Bone health and osteoporosis research
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Adrenal Hormones and Disorders
  • Adrenal Hormones and Disorders
  • Ovarian function and disorders
  • Bone health and osteoporosis research
  • Bone health and osteoporosis research
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Ophthalmology and Eye Disorders
  • Pancreatic function and diabetes
  • Hormonal Regulation and Hypertension
  • Hormonal Regulation and Hypertension
  • Ovarian function and disorders
  • Ovarian function and disorders
  • Nutrition and Health Studies
  • Nutrition and Health Studies
  • Hypothalamic control of reproductive hormones
  • Ophthalmology and Eye Disorders
  • Ophthalmology and Eye Disorders
  • Vitamin D Research Studies
  • Metabolism, Diabetes, and Cancer
  • Vitamin D Research Studies
  • Metabolism, Diabetes, and Cancer
  • Diabetes and associated disorders
  • Hormonal and reproductive studies
  • Diabetes and associated disorders
  • Diabetes and associated disorders
  • Regulation of Appetite and Obesity
  • Bone health and treatments
  • Bone health and treatments
  • Menopause: Health Impacts and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Treatment and Management
  • Genetic Syndromes and Imprinting
  • Diabetes Treatment and Management
  • MicroRNA in disease regulation
  • Regulation of Appetite and Obesity
  • Genetic Syndromes and Imprinting
  • Regulation of Appetite and Obesity
  • Pancreatic function and diabetes
  • Pancreatic function and diabetes
  • Hormonal Regulation and Hypertension
  • Bone Metabolism and Diseases
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism

Keywords (DOAJ)

  • therapy
  • hormones
  • secretion
  • metabolism
  • diabetes
  • endocrinology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: